Katelyn Weaver
Nurse Practitioner · Grand Junction, CONPI 1114580271
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $854 of the $1,281 with a category attached, or 66.7%. Medical Device Business Services, Inc. accounts for 78.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $1,092 and has fallen 98.1% since, to $21 in 2025.
Across 16 payments — averaging $80.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Johnson & Johnson$86
- AstraZeneca$48
- Grifols USA, LLC$22
- Actelion Pharmaceuticals US, Inc.$22
- Mylan Specialty L.p.$21
- plus $76 from 4 others
What the payments were for
- Travel & lodging$85467%
- Food & beverage$42733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $1,005 |
| Johnson & Johnson | 2 | $86 |
| AstraZeneca | 3 | $48 |
| Grifols USA, LLC | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| GSK | 1 | $21 |
| Davol Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,281 in reported general payments places this provider in the 85th percentile of 1,384 nurse practitioner providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 27 | $38,391 |
| Dexlansoprazole DrDexlansoprazole | 17 | $5,205 |
| Omeprazole | 19 | $138 |
| Topiramate | 25 | $125 |
| Famotidine | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Grand Junction
- Lori WenzGrand Junction$54K
- Beverly JucknathGrand Junction$10K
- Heather WinfieldGrand Junction$8K
- Katrina MetcalfGrand Junction$5K
- Deborah HinnenColorado Springs$388K
- Christina HansonLone Tree$381K
- Kara HartPueblo$142K
- Amy SidorskiAurora$97K
- Lisa KeithColorado Springs$52K
- Victoria SegroEnglewood$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.